Towa Pharmaceutical Co., Ltd. (TWAPF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Towa Pharmaceutical Co., Ltd.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
37.55
Weak
WeakModerateStrong
P/B Ratio
1.11
Strong
WeakModerateStrong
Earnings Yield
2.66%
Yield Trap
WeakModerateStrong
Profitability Health
2026Return on Equity
2.95%
Weak
WeakModerateStrong
Operating Margin
8.44%
Weak
WeakModerateStrong
Net Profit Margin
1.92%
Weak
WeakModerateStrong
Growth Indicators
2026Revenue Growth
6.10%
Moderate
WeakModerateStrong
Net Income Growth
-72.17%
Weak
WeakModerateStrong
EPS Growth
-72.25%
Weak
WeakModerateStrong
Efficiency & Liquidity
2026Current Ratio
2.76
Strong
WeakModerateStrong
Quick Ratio
1.49
Moderate
WeakModerateStrong
Asset Turnover
0.58x
Moderate
WeakModerateStrong
Inventory Turnover
1.41x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
4.13%
Strong
WeakModerateStrong
EV / Free Cash Flow
46.44x
Weak
WeakModerateStrong
Net Debt / EBITDA
4.74x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.570
Weak
WeakModerateStrong
Return on Invested Capital
2.25%
Weak
WeakModerateStrong
Cash Conversion Cycle
286.99 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for TWAPF.
View Financial Statements